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Direct reprogramming of human fibroblasts to a plu-
ripotent state has been achieved through ectopic ex-
pression of the transcription factors OCT4, SOX2,
and either cMYC and KLF4 or NANOG and LIN28. Lit-
tle is known, however, about the mechanisms by
which reprogramming occurs, which is in part limited
by the low efficiency of conversion. To this end, we
sought to create a doxycycline-inducible lentiviral
system to convert primary human fibroblasts and
keratinocytes into human induced pluripotent stem
cells (hiPSCs). hiPSCs generated with this system
were molecularly and functionally similar to human
embryonic stem cells (hESCs), demonstrated by
gene expression profiles, DNA methylation status,
and differentiation potential. While expression of
the viral transgenes was required for several weeks
in fibroblasts, we found that 10 days was sufficient
for the reprogramming of keratinocytes. Using our in-
ducible system, we developed a strategy to induce
hiPSC formation at high frequency. Upon addition
of doxycycline to hiPSC-derived differentiated cells,
we obtained ‘‘secondary’’ hiPSCs at a frequency at
least 100-fold greater than the initial conversion.
The ability to reprogram cells at high efficiency pro-
vides a unique platform to dissect the underlying
molecular and biochemical processes that accom-
pany nuclear reprogramming.
INTRODUCTION
While human fibroblasts and a multitude of mouse somatic cell
types can be reprogrammed to pluripotency by ectopic expres-
sion of transcription factors (Takahashi and Yamanaka, 2006;
Maherali et al., 2007; Okita et al., 2007; Wernig et al., 2007;
Takahashi et al., 2007; Yu et al., 2007; Lowry et al., 2008; Aoi
et al., 2008; Hanna et al., 2008; Stadtfeld et al., 2008a), the con-340 Cell Stem Cell 3, 340–345, September 11, 2008 ª2008 Elsevierversion is highly inefficient (0.01%), making it difficult to exam-
ine the underlying molecular events. Further, all hiPSCs to date
have been generated with retroviruses and noninducible lentivi-
ruses, both of which are inefficiently silenced andmaintain trans-
gene expression. Another limitation in the generation of hiPSCs
is the efficiency of viral gene transduction. While the fraction of
cells infected by each individual factor and combinations of fac-
tors have not been addressed, only a small proportion of cells
likely receive all factors. To overcome these limitations, we
have established an inducible lentiviral system to generate ‘‘sec-
ondary’’ pluripotent cells, in which hiPSC clones are differenti-
ated in vitro to yield fibroblast-like cells that harbor the inducible
viral transgenes required for reprogramming. Because these
cells maintain the same viral integrations that mediated the initial
conversion to hiPSCs, this system bypasses the need for direct
viral infection and produces a population of cells that can indu-
cibly and homogeneously express the reprogramming factors.
Such a system provides a powerful tool for mechanistic analysis,
chemical and genetic screening for factors that enhance or block
reprogramming, and the optimization of hiPSC derivation
methods.
RESULTS
cDNAs encoding human OCT4, SOX2, cMYC, KLF4, and
NANOG were cloned into doxycycline (Dox)-inducible lentiviral
vectors as previously described (Stadtfeld et al., 2008b). In addi-
tion, a reverse tetracycline transactivator (rtTA) driven by the
ubiquitin promoter was cloned into a lentiviral vector. To gener-
ate hiPSCs, we infected neonatal foreskin fibroblasts (BJ) and
keratinocytes with lentiviruses containing the rtTA and either
four (OCT4, SOX2, cMYC, and KLF4; for fibroblasts only) or
five reprogramming factors (4 + NANOG; both fibroblasts and
keratinocytes) according to the scheme in Figure 1A. Following
infection, cells were plated onto mouse embryonic fibroblast
feeder cells (MEFs) under hESC conditions and induced with
Dox. From the fibroblast cultures, non-hESC-like colonies
emerged approximately 2 weeks after the addition of Dox, as
previously observed (Takahashi et al., 2007). These colonies
contained only Oct4 and Myc integrations and could not beInc.
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Efficient Generation of Human iPSCsFigure 1. Generation of hiPSCs Using Inducible Lentiviruses
(A) Experimental scheme for the generation of hiPSCs. Primary human fibroblasts and keratinocytes were infectedwith separate lentiviruses (LV) containing a con-
stitutively active rtTA and Dox-inducible reprogramming factors. After infection, cells were seeded to feeders, and Dox was applied for 30 days. hiPSC clones
were picked based on hESC-like morphology and Dox-independent growth.
(B) Morphology and marker expression in hiPSC colonies. Dox-independent fibroblast- and keratinocyte-derived hiPSCs express OCT4 protein.
(C) Microarray analysis of gene expression in hiPSCs. Genes with greater than 2-fold expression level between HUES8 hESCs and BJ fibroblasts were analyzed.
Shown are BJ fibroblasts, HUES8 hESCs, and BJ fibroblast-derived hiPSC clones.
(D) In vitro differentiation of fibroblast-derived hiPSCs into lineages from all three germ layers. Immunostaining for (i) Tuj1 (neuronal), (ii) cardiac troponin T (cTnT;
cardiac muscle), and (iii) alpha-fetoprotein (AFP; epithelial, early endodermal).
(E) In vitro differentiation of keratinocyte-derived hiPSCs into lineages from all three germ layers. Immunostaining for (i) Tuj1, (ii) skeletal muscle (MF20), and (iii)
alpha-fetoprotein.
(F) Hematoxylin and eosin stain of teratomas generated from fibroblast-derived hiPSCs. Differentiated structures from all three germ layers were present. (i) Pig-
mented epithelium (ectoderm), (ii) cartilage (mesoderm), (iii) gut-like epithelium (endoderm), and (iv) muscle (mesoderm).expanded in the absence of Dox (data not shown). After 30 days
of culture, colonies that resembled hESCs were observed, noted
by a high nucleus-to-cytoplasmic ratio, prominent nucleoli, and
well-defined phase-bright borders. All hESC-like colonies ex-
pressed the hESC-specific surface antigen Tra-1-81 (data not
shown) and could be expanded in the absence of Dox. Colonies
that did not resemble hESCs did not express Tra-1-81 and could
not be passaged independent of Dox. Of 2.5 3 105 infectedCell Sfibroblasts seeded, four iPS colonies were obtained from each
condition (four- or five-factor), representing a frequency of
0.002%. From the keratinocyte cultures, large non-ES-like col-
onies appeared within 1 week; within 3 weeks, hESC-like colo-
nies appeared and could be passaged in the absence of Dox.
Of 3 3 105 cells seeded, seven colonies emerged, similar to
the frequency observed for hiPSC derivation from fibroblasts
(0.002%).tem Cell 3, 340–345, September 11, 2008 ª2008 Elsevier Inc. 341
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hESC-specific surface antigen Tra-1-81 (Figure 1B and data
not shown). Further, these cells showed expression of pluripo-
tency genes from the endogenous loci and lacked expression
of the viral transgenes (see Figure S1A available online). To as-
sess whether hiPSCs were molecularly similar to hESCs, we
examined promoter methylation and performed global transcrip-
tional analysis. The NANOG and OCT4 promoters in fibroblast-
derived hiPSCs were demethylated to a similar extent as in
hESCs, in contrast to the highly methylated promoters in BJ
fibroblasts (Figure S1B), thus demonstrating epigenetic reprog-
ramming in hiPSCs. Global analysis of gene expression in fibro-
blast-derived hiPSCs, hESCs, and fibroblasts was conducted by
microarray through comparison of differentially expressed genes
between fibroblasts and hESCs (Figure 1C), indicating that
hiPSCs had repressed the fibroblast program of gene expres-
sion and reactivated an embryonic program of transcription.
Pluripotency of both fibroblast- and keratinocyte-derived
hiPSCs was examined in vitro through embryoid body (EB) for-
mation. After 7 days in suspension culture, EBs were explanted
and gave rise to well-defined neuronal outgrowths and beating
cardiomyocyte structures (data not shown). Immunofluores-
cence analysis confirmed the presence of neurons, cardiomyo-
cytes, skeletal muscle cells, and epithelial structures (Figures
1D and 1E), thus demonstrating multilineage differentiation. As
a more stringent test of pluripotency, fibroblast-derived hiPSCs
cells were injected either subcutaneously or under the kidney
capsule of immunodeficient SCIDmice to assay for teratoma for-
mation. Tumors were recovered after 10 weeks and contained
well-defined structures arising from all three embryonic germ
layers, including pigmented cells, cartilage, skeletal muscle,
and gut-like epithelium (Figure 1F). These results indicate that
hiPSCs generated with an inducible system strongly resemble
hESCs and fulfill all criteria for pluripotency.
Noting that keratinocyte-derived hiPSC colonies appeared
faster than fibroblast-derived hiPSCs, we sought to determine
the minimum amount of time required to convert keratinocytes
to hiPSCs. To test this, keratinocytes were infected with rtTA
and five factors (OCT4, SOX2, cMYC, KLF4, and NANOG), and
Dox was withdrawn at different time points throughout the re-
programming process. The number of hESC-like colonies was
counted at day 30 and plotted against the day of Dox withdrawal
(Figure S1C). hESC-like colonies first appeared after 18 days
whenDoxhadbeenwithdrawnafter 10days. The frequencyof re-
programming appeared to decline with the length of Dox expo-
sure, which may reflect unfavorable culture conditions at later
timepointsor adverseeffectsof continued transgeneexpression.
To establish the system of ‘‘secondary’’ hiPSCs, we differenti-
ated several fibroblast-derived hiPSC clones to fibroblast-like
cells in vitro according to the scheme in Figure 2A. hiPSC colo-
nies were placed in suspension culture for 1 week, and the re-
sulting EBswere then plated to adherent conditions. Outgrowths
of fibroblast-like cells were picked and passaged a minimum of
three times prior to experimental manipulation to ensure that no
residual pluripotent cells were present. Quantitative RT-PCR
analysis confirmed a lack of pluripotency gene expression in
these populations (Figure S2A).
We assessed the ability of hiPSC-derived cells to generate
‘‘secondary’’ hiPSCs through Dox addition and transfer to hiPSC342 Cell Stem Cell 3, 340–345, September 11, 2008 ª2008 Elsevierderivation conditions. Fibroblast-like cells derived from two
hiPSC clones demonstrated reprogramming in the presence,
but not absence, of Dox (Figure 2B). The frequency of conversion
ranged from 1% to 3%. Reinduction of viral transgenes in hiPSC-
derived fibroblasts clones was also assessed by quantitative
RT-PCR (Figure S2B), demonstrating a correlation between
factor reactivation and the ability of the clone to produce sec-
ondary hiPSCs. Clones that gave rise to secondary hiPSCs
showed reactivation of all factors (BJ hiPSCs #11 and #12), while
those that did not lacked re-expression of a factor (BJ hiPSC #5)
or re-expressed the factors at levels that are likely not permissive
for the induction of pluripotency (BJ hiPSC #8).
Secondary hiPSCsweremolecularly and functionally similar to
primary hiPSCs and hESCs. They stained positive for OCT4 and
Tra-1-81 (Figure 2C), had a similar gene expression profile to
hESCs (Figure 2D), and demonstrated pluripotency in vitro,
generating cell types from all three embryonic germ layers
(Figure 2E).
To determine the temporal requirement of transgene expres-
sion for secondary hiPSC formation, we seeded 104 fibroblast-
like cells per time point under hiPSC derivation conditions and
withdrew Dox daily from days 4–19. The final number of Tra-1-
81+ hESC-like colonies was counted at day 25 (Figure 2F). hiPSC
colonies began to appear after withdrawal of Dox at day 6 (one
colony), and the number of colonies increased with the time of
Dox exposure, reaching a maximum after withdrawal at 16
days (frequency of 2%). This increase in frequency with length
of Dox exposure has also been reported in the reprogramming
of mouse cells (Wernig et al., 2008).
Transformed granular colonies did not appear during second-
ary hiPSC induction, in contrast to the early colonies that ap-
peared during primary induction with direct viral infection. The
lack of these background colonies coupled with the high
efficiency of the secondary system enabled us to monitor the
progression of colonies during reprogramming. We tracked indi-
vidual colonies on a daily basis with different time points of Dox
withdrawal (Figure S3) and observed that induced cells transited
through non-ES-like structures prior to acquiring a hiPSC pheno-
type. Not all colonies developed fully to hiPSCs; those that did
not undergo successful reprogramming began to regress
2 days after Dox withdrawal and ultimately formed fibroblast-
like structures. The colonies that successfully generated hiPSCs
also showed some regression after withdrawal of Dox; however,
hESC-like outgrowths gradually appeared, which could be ex-
panded into stable hiPSC lines.
DISCUSSION
Here we have described the use of an inducible lentiviral system
for the reprogramming of human somatic cells. Using this sys-
tem, we converted neonatal foreskin fibroblasts and keratino-
cytes to a pluripotent state molecularly and functionally similar
to hESCs. This system also enabled us to establish the temporal
requirement of factor expression for cells undergoing reprog-
ramming. While fibroblasts relied on transgene expression for
several weeks, keratinocytes required only 10 days of factor
expression to revert to a state that was poised to become plurip-
otent. It is unknown why keratinocytes are more amenable to re-
programming. Keratinocytes, like hESCs, represent an epithelialInc.
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(A) Experimental scheme depicting the generation of secondary hiPSCs. hiPSCswere differentiated in vitro as embryoid bodies for 7 days, then plated to adherent
conditions. Fibroblast-like colonies were picked and expanded for at least three passages prior to undergoing reinduction by Dox.
(B) Alkaline phosphatase staining of reprogrammable cells grown in the absence or presence of Dox. Doxwaswithdrawn at day 21, and colonies were stained and
counted at day 30.
(C) Morphology and expression of OCT4 and Tra-1-81 in Dox-independent secondary hiPSCs.
(D) Microarray analysis of gene expression between BJ fibroblasts, HUES8 hESCs, primary fibroblast-derived hiPSCs, and a resulting secondary hiPSC clone.
Shown are genes with >2-fold expression value between BJ fibroblasts and HUES8 hESCs.
(E) In vitro differentiation of secondary hiPSCs into lineages from all three germ layers. Immunostaining for (i) Tuj1, (ii) cardiac troponin T, and (iii) alpha-fetoprotein.
(F) Temporal requirement of factor expression in hiPSC-derived fibroblast-like cells. 104 cells were plated per time point, and Dox was withdrawn daily from days
4–19. The hESC-like colonies that expressed Tra-1-81 were counted at day 25.Cell Stem Cell 3, 340–345, September 11, 2008 ª2008 Elsevier Inc. 343
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a mesenchymal-epithelial transition during reprogramming
(Yang and Weinberg, 2008). Differences in reprogrammability
between fibroblasts and keratinocytes may also be explained
by differences in the cell-cycle status or viral infectivity. More-
over, keratinocytes express much higher levels of endogenous
MYC and KLF4 than fibroblasts (Figure S1A), which may accel-
erate their conversion to hiPSCs. The fast kinetics of reprogram-
ming observed for keratinocytes suggests that these cells would
be useful for the development and optimization of methods to re-
program cells by transient delivery of factors.
Controlled expression of the reprogramming factors provided
an inherent selection strategy by eliminating cells that were de-
pendent upon viral transgene expression andconferring agrowth
advantage to fully reprogrammed cells that were Dox indepen-
dent. This is in contrast to the constitutive retro- and lentiviral
systems that have so far been used to reprogram human cells,
where the viral transgenes maintain expression in the hiPSC
state. The persistence of viral gene expression could have dele-
terious effects in clinical applications such as in vitro disease
modeling; for example, the overexpression of Oct4 or Sox2
has been shown to promote the differentiation of mouse ES cells
(Niwa et al., 2000; Kopp et al., 2008), suggesting that their con-
tinued expression during in vitro differentiation of hiPSCs may
bias the resulting cell fate.
The extremely low efficiency of reprogramming led us to de-
velop a system of ‘‘secondary’’ pluripotent cells in which we
could reprogram hiPSC-derived differentiated cells at a high fre-
quency. The >100-fold increase we observed was likely attrib-
uted to the ability to reactivate all factors within a given cell,
thus enabling efficient reprogramming. The kinetics of this pro-
cess were faster than that of primary fibroblasts but similar
to keratinocytes, with the highest efficiency occurring after
16 days of factor expression. In vitro-derived fibroblasts ap-
peared to be more amenable to reprogramming than primary fi-
broblasts, as previously observed (Yu et al., 2007; Park et al.,
2008), which may reflect a lack of exposure to potent differenti-
ation cues in vitro. However, four lines of evidence suggest that
the reprogramming of hiPSC-derived differentiated cells is rep-
resentative of the process that occurs in primary cells: (1)
hiPSC-derived fibroblast-like cells lacked detectable expression
of key pluripotency genes, (2) no colonies formed in the absence
of Dox, (3) clones that did not reactivate all factors could not suc-
cessfully form secondary hiPSCs, and (4) visual tracking of colo-
nies demonstrated that cells transit through a non-hESC-like
state prior to becoming bona fide hiPSC colonies. These data
collectively support the use of a secondary system as a platform
for mechanistic dissection of the reprogramming process.
Despite the fact that viral transgenes were reactivated in most
of the hiPSC-derived cells, the frequency of reprogramming re-
mained quite low, ranging from 1% to 3%. The basis for the
low efficiency is poorly understood but may reflect a multitude
of factors such as the starting cell type, cell-cycle status and
the ability to undergo replication, variability in factor reactivation,
and other stochastic events. Epigenetic events have been impli-
cated in the reprogramming process; for example, it has recently
been shown that valproic acid, which acts primarily as a histone
deacetylase inhibitor, can enhance the efficiency of reprogram-
ming (Huangfu et al., 2008). Also, DNA methylation and the acti-344 Cell Stem Cell 3, 340–345, September 11, 2008 ª2008 Elseviervation of differentiation pathways have been shown to impede
the reprogramming of mouse fibroblasts (Mikkelsen et al.,
2008). However, these events account only for a small proportion
of cells, and it will be interesting to further define the limiting fac-
tors that constrain the efficiency of reprogramming.
The secondary system of hiPSCs presents an attractive model
forwhich to study themolecular events that underlie the reversion
of human somatic cells to a pluripotent state. By providing
a homogeneous population of cells that harbor all the viral trans-
genes, the cultures are not subject to the background of cells that
do not receive all factors, allowing proper analysis of the reprog-
ramming process. The secondary system will enable chemical
and genetic screening efforts to identify key molecular constitu-
ents of reprogramming, as well as important obstacles in this
process, and will ultimately lend itself as a powerful tool in the
development and optimization of methods to produce hiPSCs.
EXPERIMENTAL PROCEDURES
Virus Production
Vectors were constructed as previously described (Stadtfeld et al., 2008b). To
generate virus, 293T cells were transfected at 30% confluence using FuGENE
6 reagent (Roche). For a 10 cm plate, 560 mL DMEM, 27 mL FuGENE, and 12 mg
DNA (4:3:2 vector:D8.9:vsv-g) were used. Virus was harvested over 3 days and
concentrated 300-fold. For a standard infection in a 35 mm dish (105 cells),
10 mL rtTA + 5 mL factors (OCT4, SOX2, KLF4, and NANOG) + 2 mL cMYC
was used in an overnight infection supplemented with 6 mg/mL polybrene.
Cell Culture and hiPSC Generation
Fibroblasts were grown in DMEM with 10% FBS, nonessential amino acids,
glutamine, and b-mercaptoethanol; keratinocytes were cultured on collagen
IV in keratinocyte serum-freemedium and growth supplement (Invitrogen). Hu-
man ES and iPS cells were cultured as previously described (Cowan et al.,
2004). hiPSCs were generated as follows: day 0, to 1 mg/mL Dox in hESC me-
dia + 2% defined FBS (GIBCO) for fibroblasts, 1% FBS for keratinocytes;
day 2, hESC + 1 mg/mL Dox + 1% FBS (fibroblasts) or hESC + Dox (keratino-
cytes); day 4, hESC + 1 mg/mL Dox; day 10, hESC + 0.5 mg/mL Dox (continued
until colonies appeared).
Differentiation
For in vitro differentiation, hiPSC colonies were mechanically picked and
placed in suspension culture with fibroblast media. After 1 week, embryoid
bodies were plated to adherent conditions with gelatin. For teratoma forma-
tion, 107 hiPSCs were pelleted and injected into SCID mice, either subcuta-
neously above the dorsal flank or underneath the kidney capsule. Tumors were
harvested after 10–12 weeks and processed for histological analysis.
Bisulfite Sequencing
Genomic DNA was converted using the Epitect bisulfite kit (QIAGEN). OCT4
and NANOG promoters were PCR amplified using primers listed in Table S2.
PCR products were cloned into TOPO vectors and sequenced.
Immunostaining
Immunostaining was performed using the following antibodies: a-Oct4
(sc-8628, Santa Cruz Biotech), a-Tra-1-81 (MAB4381, Millipore), a-b-III tubulin
(T2200, Sigma), a-cardiac troponin T (clone 13-11, Neomarkers), a-myosin
heavy chain (clone MF20, Developmental Studies Hybridoma Bank), and
a-AFP (sc-15375, Santa Cruz Biotech).
qPCR
RNA was extracted by using a QIAGEN RNeasy kit, then converted to cDNA
with the Superscript III First-Strand synthesis system (Invitrogen) using
oligo-dT primers. qRT-PCRs were carried out using Brilliant II SYBR Green
mix (Stratagene) and run on a Stratagene MXPro400. Reactions were carried
out in duplicate with RT controls, and data were analyzed using the delta-
delta Ct method. Primer sequences are listed in Table S2.Inc.
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Total RNA was isolated using an RNeasy kit (QIAGEN). Samples were pro-
cessed as independent triplicates. RNA probes for microarray hybridization
were prepared and hybridized to Affymetrix HGU133 plus two oligonucleotide
microarrays. Data were extracted and analyzed using the Rosetta Resolver
system. During importation, the data were subjected to background correc-
tion, intrachip normalization, and the Rosetta Resolver Affymetrix GeneChip
error model (Weng et al., 2006). For the generation of intensity plots, genes
that showed greater than a 2-fold difference in expression value (p < 0.01) in
HUES8 hESCs and BJ fibroblasts were noted (19,663 probes) and their ex-
pression analyzed. A hierarchical clustering was performed.
ACCESSION NUMBERS
Microarray data have been deposited under Gene Expression Omnibus (GEO)
accession number GSE12390.
SUPPLEMENTAL DATA
The Supplemental Data include three figures and two tables and can be found
with this article online at http://www.cellstemcell.com/cgi/content/full/3/3/
340/DC1/.
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